Cell therapy needs rigorous translational studies in large animal models

Journal of the American College of Cardiology

Volumn 66, Issue 18, 2015, Pages 2000-2004

  Bolli, Roberto ^a   Ghafghazi, Shahab ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

cardiac stem cells; cell therapy; congestive heart failure; ischemic cardiomyopathy; large animal models; mesenchymal stem cells

Indexed keywords

ANIMAL MODEL; CARDIAC STEM CELL; CELL THERAPY; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE REMODELING; HUMAN; IMMUNE RESPONSE; ISCHEMIC CARDIOMYOPATHY; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR BIOLOGY; MURINE MODEL; NONHUMAN; NOTE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PORCINE MODEL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TRANSLATIONAL RESEARCH; ANIMAL; CARDIOMYOPATHY; COMPLICATION; MYOBLAST; PROCEDURES; REPERFUSION INJURY; TRANSPLANTATION;

ANIMALS; CARDIOMYOPATHIES; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOBLASTS, CARDIAC; MYOCARDIAL REPERFUSION INJURY;

EID: 84945305848     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.09.002     Document Type: Editorial

References (19)

1. S.K. Sanganalmath, and R. Bolli Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions Circ Res 113 2013 810 834
2. M.C. Keith, and R. Bolli "String theory" of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results Circ Res 116 2015 1216 1230
3. J. Mestas, and C.C. Hughes Of mice and not men: differences between mouse and human immunology J Immunol 172 2004 2731 2738
4. V. Karantalis, V.Y. Suncion-Loescher, L. Bagno, and et al. Synergistic effects of combined cell therapy for chronic ischemic cardiomyopathy J Am Coll Cardiol 66 2015 1990 1999
5. A.R. Williams, K.E. Hatzistergos, B. Addicott, and et al. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction Circulation 127 2013 213 223
6. T.D. Henry, J.H. Traverse, B.L. Hammon, and et al. Safety and efficacy of ixmyelocel-T: an expanded, autologous multi-cellular therapy, in dilated cardiomyopathy Circ Res 115 2014 730 737
7. F.C. McCall, K.S. Telukuntla, V. Karantalis, and et al. Myocardial infarction and intramyocardial injection models in swine Nat Protoc 7 2012 1479 1496
8. R. Bolli, A.R. Chugh, D. D'Amario, and et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial Lancet 378 2011 1847 1857
9. V. Karantalis, and J.M. Hare Use of mesenchymal stem cells for therapy of cardiac disease Circ Res 116 2015 1413 1430
10. E. Avolio, M. Meloni, H.L. Spencer, and et al. Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair Circ Res 116 2015 e81 e94
11. E.M. Winter, A.A. van Oorschot, B. Hogers, and et al. A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells Circ Heart Fail 2 2009 643 653
12. N. Latham, B. Ye, R. Jackson, and et al. Human blood and cardiac stem cells synergize to enhance cardiac repair when cotransplanted into ischemic myocardium Circulation 128 2013 S105 S112
13. T. Li, Q. Ma, M. Ning, Y. Zhao, and Y. Hou Cotransplantation of human umbilical cord-derived mesenchymal stem cells and umbilical cord blood-derived CD34(+) cells in a rabbit model of myocardial infarction Mol Cell Biochem 387 2014 91 100
14. H.C. Ott, N. Bonaros, R. Marksteiner, and et al. Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats Eur J Cardiothorac Surg 25 2004 627 634
15. I.A. Memon, Y. Sawa, S. Miyagawa, S. Taketani, and H. Matsuda Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy J Thorac Cardiovasc Surg 130 2005 646 653
16. N. Bonaros, R. Rauf, D. Wolf, and et al. Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure J Thorac Cardiovasc Surg 132 2006 1321 1328
17. E.J. Suuronen, J. Price, J.P. Veinot, and et al. Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function J Thorac Cardiovasc Surg 134 2007 1249 1258
18. N. Bonaros, R. Rauf, E. Werner, and et al. Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure Interact Cardiovasc Thorac Surg 7 2008 249 255
19. S.P. Jones, X.L. Tang, Y. Guo, and et al. The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs Circ Res 116 2015 572 586